Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

6.7K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
6.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

1.6K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Technology-assisted physical activity among hospitalized medical patients: a cluster randomized trial.

European journal of preventive cardiology·2026
Same author

Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population.

European heart journal·2026
Same author

Validating National Registry Data for Randomised Trials: Comparison of registry-derived cardiovascular events with and without adjudication in the BETAMI-DANBLOCK trial.

European heart journal. Quality of care & clinical outcomes·2026
Same author

Beta-blockers, depression, and anxiety after myocardial infarction: the BETAMI-DANBLOCK trial.

European heart journal·2026
Same author

From paper charts to precision prevention: why cardiovascular risk estimation must move online.

European heart journal. Quality of care & clinical outcomes·2026
Same author

Heart failure etiology and lipoprotein subfractions: Insight from the SMARTEX-HF study.

International journal of cardiology. Heart & vasculature·2026

Related Experiment Video

Updated: May 5, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

7.9K

Interval training does not modulate diastolic function in heart transplant recipients.

Tea Monk-Hansen1, Christian H Dall, Stefan B Christensen

  • 1Department of Cardiology, Bispebjerg University Hospital , Copenhagen , Denmark.

Scandinavian Cardiovascular Journal : SCJ
|December 11, 2013
PubMed
Summary
This summary is machine-generated.

Aerobic interval training improved exercise capacity in heart transplant recipients but did not significantly alter diastolic function. Peripheral factors likely limit exercise performance more than diastolic dysfunction in these patients.

More Related Videos

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K
A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation
09:12

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation

Published on: April 27, 2019

8.9K

Related Experiment Videos

Last Updated: May 5, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

7.9K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K
A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation
09:12

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation

Published on: April 27, 2019

8.9K

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Transplantation Medicine

Background:

  • Heart transplant (HTx) recipients often experience limited exercise capacity.
  • Diastolic dysfunction is a potential contributor to reduced exercise tolerance post-transplant.

Purpose of the Study:

  • To evaluate the impact of aerobic interval training on diastolic function at rest and during exercise in stable HTx recipients.
  • To determine if improvements in diastolic function correlate with enhanced exercise capacity.

Main Methods:

  • A randomized controlled trial involving 23 stable HTx recipients.
  • An 8-week intensive aerobic interval training program compared to a control group.

Main Results:

  • Aerobic interval training significantly increased peak oxygen consumption (VO2 peak) in the intervention group compared to controls.
  • No consistent improvements in diastolic function, assessed by E/e', E/A ratio, and deceleration time, were observed at rest or during exercise.
  • Baseline diastolic function did not correlate with VO2 peak.

Conclusions:

  • Diastolic dysfunction does not appear to be the primary limitation for exercise capacity in stable HTx recipients.
  • Peripheral factors are likely more significant contributors to exercise limitation in this population.
  • Aerobic interval training enhances cardiorespiratory fitness but does not substantially improve diastolic function in HTx recipients.